Lessons from the PROVE-IT trial. Higher dose of potent statin better for high-risk patients.
Khush
Kiran K
KK
Division of Cardiology, Department of Medicine, University of California, San Francisco 94143, USA. kkhush@medicine.ucsf.edu
Waters
David
D
D002318:Cardiovascular Diseases / Q000517:prevention & control; D008078:Cholesterol, LDL / Q000097:blood; D004305:Dose-Response Relationship, Drug; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000008:administration & dosage*; D006937:Hypercholesterolemia / Q000188:drug therapy*; D017035:Pravastatin / Q000008:administration & dosage*; D016032:Randomized Controlled Trials as Topic
D008078:Cholesterol, LDL; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D017035:Pravastatin